30 Nov - 11 Dec 2020
THE digital congress for neurotechnology innovation and growth,
This interactive 2-week virtual conference hosted by neurotech.com features keynote speakers, panels, interviews, breakout sessions, networking opportunities ... and more.
PROGRAM
Neuro-gaming : Biohacking and new devices : Wearables : Surface stimulation : Bio feedback : HRV/EMG : Nootropics : Neurofeedback: EEG
Neuroimaging : Treatments for Alzheimer’s and cognitive disorders : Conquering paralysis : Neuromodulation : Neuroethics : Brain computer interfaces
Neuroceuticals : Electroceuticals : GABA : Dopamine : Serotonin : Behavioural Neuropharmacology : New modalities in epilepsy : Next-generation psychiatry : Spinal cord stimulation
Neurological biomarkers : Cognitive assessment : Overcoming the obstacles of brain-computer interfacing : Diagnostic medicine : Singularity : Neuroprotection : Ethical analysis, neuroethics and the social impact of brain machine interface : Neuroprosthetics : The role of machine learning : Neuroergonomics - neurotech for every day
Start-up pitch events : Investment sessions : Investor panel and start ups : Neurotech IPOs/success stories (founder speech) : Industry (DARPA) : Industry groups
 

30 November & 01 December 2020

Neuro-gaming : Biohacking and new devices : Wearables : Surface stimulation : Bio feedback : HRV/EMG : Nootropics : Neurofeedback: EEG

Host introduction from Alon Braun of neurotech.com
Co-Founder: Neurotech.com
Alon Braun
 
30 November - Consumer tech: AGENDA
40 Years of Zen
Stress Reprogramming for Cognitive Enhancement
Dave Asprey
Cognixion
Say "Hello" with Cognixion's Wearable Speech™ project, a closed-loop wireless brain computer interface for augmented reality
Andreas Forsland
Muse
Fireside chat with Alon Braun about Muse
Ariel Garten
President: BrainCo
From brainwaves to action, or how to put the brain back into the brain-computer interface.
Max Newlon
Founder: Lief Therapeutics

Heart Rate Variability as a biomarker of emotion, mental health, and stress

How to improve HRV through biofeedback -Lief smart patch (demo) -Partnerships with healthcare organizations

Future of Lief's approach to mental health -Lief smart patch.

Rohan Dixit
 
Tuesday 01 December
01 December - Consumer tech: AGENDA
Founder & CEO: Eno
The impact of Focus on work in a post-COVID world, and how neurotech can help improve our productivity and adapt to the new normal.
Jacob Flood
CEO: BrainPatch
Mental health during pandemic - are there consumer neurotech solutions on the market?
Nickolai Vysokov
Co-Founder & Chief Innovation Officer: Apollo Neuroscience
Wearables, AI, and the Future of Health.
Dave Rabin
Co-Founder at BlueberryX
The history and journey of the glasses to date and where we are going in the near and long term future.
John David Chibuk
Founder & CEO: Vagus Health Ltd
The Vagus Nerve and the new 'Vagus ECG Test'. pre-video / show and tell.
Gustaf Kranck
Co-Founder: Neurable
Breaking down the consumer BCI: building Neurotech for everyday use.
Dr. Alcaide
Co-Founder: Drowzee
Drowzee - rewire your brain for better sleep.
Elisa Lesca
Chief Commercial Officer: Impulse Neiry
BCI in Education. Use Cases, Success and Obstacles.
Tatiana Aleksandrova
 

02 December & 03 December 2020

Neuroimaging : Treatments for Alzheimer’s and cognitive disorders : Conquering paralysis : Neuromodulation : Neuroethics : Brain computer interfaces

 
02 December - Research: AGENDA
Co-founder NeurotechX
Moderator
Yannick Roy
CEO and Owner: Advanced Brain Monitoring
EEG: A Vision into the Future Solutions to Neurodegenerative Disease
Chris Berka
Founder: Neural Implant Podcast and Neurotech CEO Peer Support Group
Neural Implant Podcast / Mastermind program for neurotech CEOs.
Ladan Jiracek
Ph.D. Candidate, University of Toronto
Closed-loop Brain Stimulation Systems using Artificial Intelligence. Where do we stand? What is the prospect?
Mina Mirjalili
KCL
Virtual Reality and Brain/Machine Inferface use in functional neurological disorders
Paul Shotbolt
Product Development Physicist: The Technology Partnership
Sensors for BCIs: a practical guide to mind reading.
Hannah Hare
Ph.D candidate in neurobiology, Sagol University
Slowing Motor Function Decline - Neuromuscular Synspse-on a Chip Platform for Personalized Drug Screening
Ariel Ionescu
Researcher: Imperial College London

Imperial College (introduction to the Next Generation Neural Interfaces lab)

Description of our research projects (2-3 examples of the neurotech projects we are currently working on)

Dorian Haci
CEO: Imaginostics
Quantitative neuroimaging biomarkers for precision medicine.
Codi Gharagouzloo
CEO: Senescence Life Sciences
Brain health products and personalized tracking.
Shawn Watson
 
Thursday 03 December
03 December - Research: AGENDA
Chairman Of The Board at Brainstorm IL
Moderator
National platform for increasing research dynamics and innovation.
Asaf Harel
Associate professor: Tel-Aviv University and the Head of the Neuroeconomics and Neuromarketing lab
Data on our neuromarketing study that uses a deep learning network that we developed to analyse EEG signals and predict subjects' future preferences.
Dino Levy
Professor: Bath Uni
Artificial neurons as therapies for chronic disease.
Alain Nogaret
CEO: Neuromotion
The future of mobile EEG and pervasive neurotech.
Frank Zanow
Co-founder and CSO of Bitbrain
Driving brain-computer interface research to society
Javier Minguez

CEO & Co-Founder: Mindset Technologies

Mindset 4.0

Brain health products and personalized tracking.
Christian Kusmitsch
Maroun Farah: CEO Sensomedical
Converting neuroscience research into actual marketed medical devices – processes and challenges.
Maroun Farah
President Transylvanian Institute of Neuroscience
From brainwaves to action, or how to put the brain back into the brain-computer interface.
Raul C. Muresan
Professor and President New England Complex Systems Institute, Founder endcoronvairus.org network.
Stopping COVID.
Yaneer Bar-Yam
 

04 December & 07 December 2020

Neuroceuticals : Electroceuticals : GABA : Dopamine : Serotonin : Behavioural Neuropharmacology : New modalities in epilepsy : Next-generation psychiatry : Spinal cord stimulation

 
04 December - Clinical: AGENDA
Owner at Dr Neil Paulvin
Biohacking Combining Tech and Supplements
Neil Paulvin
Founder & CEO: Neuro Device Group
Voic - a comprehensive therapy for post-stroke aphasia and other cognitive disorders.
Pawel Soluch
Neurotechnology Consultant
Part of a brain computer interface study through the University of Pittsburgh
Nathan Copeland
Founder & CEO ProtoMe Technologies
One device to rule them all? The role of multimodal imaging in epilepsy presurgical work-up.
Talk abstract: This talk with use the case-study of epilepsy clinical work-up to highlight the need for unified precision software solutions within the neurotechnology space.
Nicholas Peatfield
Founder & CEO: Neuroverse
Paving the way for brain wearables in Mental Health: BrainVitals®M revolutionizing migraine prediction.
Ricardo Gil-da-Costa
CEO: Red Light Truffles
Todd Shapiro
Vice President: Egoscue
Biohacking Combining Tech and Supplements
Brian Bradley
 
Monday 07 December
07 December - Clinical: AGENDA
The Brainstorms Vienna:
Moderators
Sabria Lagoun
The Brainstorms Vienna:
Moderators
Aniko Fejes
The Brainstorms Vienna:
Moderators
Szabolcs Biro
CEO: INBRAIN
How Graphene is helping transforming Neurotech
Carolina Aguilar
Founder & CEO: MediPace
Clinical applications of bioelectronic medicine
Victor Pikov
CEO of Evoke Neuroscience
An annual brain check at your doctor’s office: where we're at and where we're going. PLUS, what studies are showing about COVID impact on the brain.
Marinela Gombosev
Ian Burkhart Foundation
BCI Neuroprosthetics, A users prospective.
Ian Burkhart
CEO and Founder: Flow Neuroscience
How an at-home tDCS device reduces depression without the need for medication.
Daniel Mansson
Founder and CEO: BrainTap
BioHacking the Brain with Light, Sound & Vobration.
Patrick Porter
CEO of and Co-Founder: Brainkey
Brain Age - What is it? Why does is it important?
Owen Phillips
Co-founder, CEO & CFO: Blackrock Systems
Hear– Talk– See– Walk Again: Blackrock, the ‘Intel’ Inside.
Marcus Gerhardt
Founder & Chairman: Cleveland Medical Devices
Clinical Studies for Movement Disorders using Remote Patient Monitoring.
Bob Schmidt
 

08 December & 09 December 2020

Neurological biomarkers : Cognitive assessment : Overcoming the obstacles of brain-computer interfacing : Diagnostic medicine : Singularity : Neuroprotection : Ethical analysis, neuroethics and the social impact of brain machine interface : Neuroprosthetics : The role of machine learning : Neuroergonomics - neurotech for every day

 
08 December - Longevity: AGENDA
CEO & Founder: First Longevity
Moderator
Phil Newman
Professor: Departments of Neuroscience and Genetics and Stem Cell Institute Albert Einstein College of Medicine
Cell Transplantation for Neocortical Repair - Clues on How to Get There
Jean Hebert
Futurist, catalyst, author, singularitarian
From enhanced phones to enhanced brains
David Wood
MD: WellSaid.ai
Detecting and Tracking Cognitive Decline: Can Alexa Best The Academic Experts?
Randall Williams
Cofounder & CEO: Virtuleap
How VR is unlocking the neurosciences
Amir Bozorgzadeh
Author of Transhumanist Bill of Rights, Presidential Candidate
Transhumanism and the Longevity Movement
Zoltan Istvan
Futurist, Author Executive Director, Ibero-American Futurists Network (RIBER)
The death of death: neuro and biological immortality.
Jose Cordeiro
CEO & Co-Founder: Brainkey
Brain Age - What is it? Why is it important?
Owen Phillips
Founder: Bernardo Kastrup
Bernardo Kastrup's meditations on life and the universe.
Bernardo Kastrup
CEO: Nia Therapeutics
Personalized neurostimulation therapy to restore memory after brain injury and disease.
Dan Rizzuto
 
Wednesday 09 December
09 December - Longevity: AGENDA
CEO & Founder: First Longevity
Moderator
Phil Newman
Director of Ageing Research: King’s College London (ARK)
Co-host
Richard Siow
CEO & Co-Founder EnClear Therapies
Longevity, accessing CSF to clear age related toxicity from the brain and spine
Anthony DePasqua
CEO and co-founder: BIOS
BIOS Health's work in leveraging recent breakthroughs in AI and Machine Learning to isolate neural biomarkers to precisely link nerve activity to specific chronic health conditions.
Emil Hewage
Sagol School of Neuroscience
New Frontiers in Neuroscience. Neurodegenerative disease and the use of Hyperbaric Oxygen Therapy (HBOT) in Alzheimer's disease
Uri Ashery
Chief AI Officer & President: Netramark
Demo our unique interactive AI platform for R&D acceleration. This suite of technologies is allowing us to impact neurodegeneration by providing new perspectives on disorders.
Joe Geraci
CEO: Fast Future
Crossing Over - Mainstreaming the Longevity Marketplace
Rohit Talwar
M.Ed., Terasem Movement Foundation Inc.,
An interactive program for attendees including a Q&A with our android Bina48
Bruce Duncan
Chief scientist & CEO: Neural Signals Inc
Extending the longevity of locked-in people by using the speech prosthetic for silent speech.
Phil Kennedy
Biomedical Gerentologist
Cognitive Hormesis Reduces Age-Related Degeneration.
Marios Kyriazis
CEO: Sana Health
Audiovisual neuromodulation for pain, mental health relief, and improving wellbeing. A novel device undergoing multiple pivotal FDA trials.
Richard Hanbury
 

10 December thru 11 December 2020

Start-up pitch events : Investment sessions : Investor panel and start ups : Neurotech IPOs/success stories (founder speech) : Industry (DARPA) : Industry groups

 
10 December - Investment: AGENDA
CEO & Founder: First Longevity
Moderator
Phil Newman
CEO & Research Director Intheon
Past, Present, and Future Brain-Computer Interface Technologies.
Tim Mullen
Chief Scientist at Joy Ventures
Academia as the engine for new venture creation in the neurotech space.
Hagit Alon
Health and Disruptive Tech Investments
(investment banker that focuses on the early-stage transformative technology market, including neurotech)
Wesley King
Managing Partner & Co-founder: Deep Knowledge Group & NeuroTech Analytics
Convergence of NeuroTech, AgeTech, mHealth with FinTech from investors perspective. Major takeouts from the NeuroTech 2020 Industry Report.
Dmitry Kaminskiy
Partner at Axon Capital Partners
Investment in brain health for longevity.
Bruce Barclay
Founder Neurotech2020 & Co-founder neurotech.com
The secret key to your entrepreneur journey success.
Alon Braun
Partner at Longevity.Capital
New analytical reports.
Franco Cortese
CEO & Co-Founder: Longevity Card
Convergence of NeuroTech, AgeTech, mHealth with FinTech from investors perspective. Major takeouts from the NeuroTech 2020 Industry Report.
Sergey Balasanyan
Managing Partner: Longevitytech.fund
Longevitytech.fund - early stage startup investments landscape.
Petr Sramek
 
Friday 11 December
11 December - Start-up & Scale-up Slam: AGENDA
Co-founder & President: NeuroTechX Services
Moderator
Adam Sefler
Co-Founder: Mensior
A single EEG sensor application for safer workplaces and for mental status feedback to online video gamers.
Roberto Luongo
Founder and CEO: NURO
COMMUNICATION BY BRAIN  Over the past 6 years, the NURO Team has been building NUOS, the Neural Operating System.  Discover how NUOS is today emerging as the non-invasive standard for communication and computing by brain for highly incapacitated patients.
Francois Gand
Neuroscientist turned business strategist
Implantable Neuromodulation for Cognitive Enhancement.
Nick Halper
Founder and CEO, Chief Scientist and Engineer: Maaind
Mind-adaptive experiences through voice and biometrics.
Martin Dinov
Chief Technology Officer: Bionic Vision Technologies
Bionic Vision Technologies' story.
Brian Gordon
Software Engineer | Neurotechnology student
Mindlayer: no-code medical data analysis
Lorenzo Sani
Co-Founder & CEO: Purple Gaze
Purple Gaze helps to boost neuroscience research and identify brain disorders by providing high performance Eye Tracking software & hardware.
Kirill Korotaev
CEO & Founder: Bioself and Sensate
Fireside chat with Adam Sefler about Sensate.
Stefan Chmelik
Co-founder: BRAINFY
Brain Longevity – harnessing the power of cognitive enhancement.
Ioana Georgescu
Co-founder: BrainForce
Mohit Patil
CEO: Neurosity
AJ Keller is the company’s CEO. Learn about how he spent the past five years building a cash efficient company and 50% product margins. Version 3 product launches in 2021.
AJ Keller
Lead System Architect: MindAffect
Fireside chat with Adam Sefler about MindAffect.
Jason Farquhar

CONTACT US

Designed by NeuroTech Analytics Ltd | 2020